Superfolding of the Partially Unfolded Core-glycosylated Intermediate of Human P-glycoprotein into the Mature Enzyme Is Promoted by Substrate-induced Transmembrane Domain Interactions

This publication has 15 references indexed in Scilit:

• Correction of Defective Protein Kinesis of Human P-glycoprotein Mutants by Substrates and Modulators
  Journal of Biological Chemistry, 1997
• Diagnosis and reversal of multidrug resistance in paediatric cancers
  European Journal Of Cancer, 1996
• Mutational Analysis of the Predicted First Transmembrane Segment of Each Homologous Half of Human P-glycoprotein Suggests That They Are Symmetrically Arranged in the Membrane
  Journal of Biological Chemistry, 1996
• P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans.
  Proceedings of the National Academy of Sciences, 1996
• GENETIC ANALYSIS OF THE MULTIDRUG TRANSPORTER
  Annual Review of Genetics, 1995
• Rapid Purification of Human P-glycoprotein Mutants Expressed Transiently in HEK 293 Cells by Nickel-Chelate Chromatography and Characterization of their Drug-stimulated ATPase Activities
  Published by Elsevier ,1995
• P-glycoprotein
  Journal of Biological Chemistry, 1995
• P-glycoprotein Is Stably Inhibited by Vanadate-induced Trapping of Nucleotide at a Single Catalytic Site
  Published by Elsevier ,1995
• Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
  Published by Elsevier ,1994
• Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.
  Molecular and Cellular Biology, 1989